EF Intervention in Children With Severe Congenital Heart Disease
Key facts
- Who runs it
- University Children's Hospital, Zurich
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 42 people enrolled
- Started
- 1 Jul 2022
- Ended
- 14 Aug 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- E-Fit
- Record updated
- 20 December 2024
Who can take part
- Age
- 10 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Born with CHD
- Underwent cardiopulmonary bypass surgery
- No genetic syndrome detected, no known dysmorphic-syndrome
- Aged 10 to 12
- written informed consent of parents and verbal informed consent of children
- EF deficits showing in screening
Who cannot take part
- Failure to provide a signed Informed Consent
- Heart surgery without cardiopulmonary bypass
- Heart surgery not performed in Switzerland
- Any genetic syndrome detected
- large cerebral lesions (stroke, HIE) or severely neurologically impaired as a result of a serious event
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Survival rates of children with severe congenital heart disease (CHD) have increased with ongoing medical progress over the past decades. However, many children with CHD face academic challenges during adolescence, which are associated with executive dysfunction. Executive functions (EF), higher-order cognitive processes allowing goal-directed behavior, can be particularly affected in children with CHD. To improve EF in affected children, a specific EF intervention has been developed.
Read full original descriptionShow less
The intervention lasts a total of 8 weeks and is structured in 3 modules. The first module consists of a weekly strategy training in which problems resulting from executive dysfunction are addressed. Online games form the second module. These are games implemented online to promote EF through play. The third module is also based on games: The families receive several board games to play together at home. This third module is voluntary. This intervention is tested on its feasibility. As the intervention was built in a patient centered manner, we expect it to be feasible, showing in a high adherence rate and satisfaction.
The 2 groups in the trial
- InterventionTreatment being tested
The intervention group will have a play-based intervention, including online games, analogue card games as well as a weekly coaching session to enhance executive functions.
Treatment: E-Fit
- ControlNo study treatment, for comparison
The control group will get access to the online games, a list of the analogue card games used and fact sheets about possibilities to enhance executive functions in everyday life (which are used in the intervention group during the coachings) after finishing the study.
Results explained
A paper that names this trial, explained in plain words.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Executive Function and Brain Development in Adolescents With Severe Congenital Heart Disease (Teen Heart Study)
- Publications
- Multimodal personalised executive function intervention (E-Fit) for school-aged children with complex congenital heart disease in Switzerland: a randomised controlled feasibility study.BMJ open, 2026
- Multimodal personalised executive function intervention (E-Fit) for school-aged children with complex congenital heart disease: protocol for a randomised controlled feasibility study.BMJ open, 2023
- Record updated
- 20 December 2024